RAFAEL HOLDINGS, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value
RAFAEL HOLDINGS, INC. (RFL) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value of $5.27 million as of 2023-10-31, per its 10-Q filed 2023-12-14.
Discontinued › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue · last filed 2023-12-14
- 2023-10-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $5.27M.
- 2023-07-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $6.91M.
- 2023-04-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $6.78M.
- 2023-01-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $5.01M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value |
|---|---|
| 2023-10-31 | $5.27M 10-Q · filed 2023-12-14 |
| 2023-07-31 | $6.91M 10-Q · filed 2023-12-14 |
| 2023-04-30 | $6.78M 10-Q · filed 2023-06-13 |
| 2023-01-31 | $5.01M 10-Q · filed 2023-06-13 |
| 2022-10-31 | $4.64M 10-Q · filed 2023-12-14 |
| 2022-07-31 | $4.76M 10-Q · filed 2023-12-14 |
| 2022-04-30 | $4.68M 10-Q · filed 2023-06-13 |
| 2022-01-31 | $5.03M 10-Q · filed 2023-06-13 |
| 2021-10-31 | $5.48M 10-Q · filed 2023-03-14 |
| 2021-07-31 | $5.27M 10-K · filed 2023-10-30 |
| 2021-04-30 | $9.68M 10-Q · filed 2022-06-14 |
| 2021-01-31 | $8.94M 10-Q · filed 2022-06-14 |
| 2020-10-31 | $6.45M 10-Q · filed 2022-03-17 |
| 2020-07-31 | $7.51M 10-K · filed 2022-10-31 |
| 2020-04-30 | $5.62M 10-Q · filed 2021-06-14 |
| 2020-01-31 | $5.64M 10-Q · filed 2021-03-17 |
| 2019-10-31 | $5.09M 10-Q · filed 2020-12-15 |
| 2019-07-31 | $5.13M 10-K · filed 2021-10-18 |
| 2019-04-30 | $4.63M 10-Q · filed 2020-06-09 |
| 2018-07-31 | $12.12M 10-K · filed 2020-10-29 |
| 2018-04-30 | $6.30M 10-Q · filed 2018-06-11 |
| 2018-01-31 | $6.30M 10-Q · filed 2018-03-12 |
| 2017-07-31 | $6.30M 10-Q · filed 2018-06-11 |
| 2017-04-30 | $4.20M 10-Q · filed 2018-06-11 |
| 2017-01-31 | $4.20M 10-Q · filed 2018-03-12 |
| 2016-07-31 | $2.00M 10-Q · filed 2018-06-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |